window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Artificial Intelligence,Clinical Trials,Digital Health,Drug Development,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    QuantHealth secures strategic investment from Sanofi Ventures to accelerate AI-driven clinical trials

    QuantHealth, a pioneer in AI-driven clinical trial simulation, has received [...]

    October 1, 2025
  • Biomanufacturing,Biotech,Drug Development,Research & Development,Technology and platforms

    Abselion extends Amperia platform with Protein G kit for broader antibody quantification

    Abselion has expanded its Amperia benchtop platform with a new [...]

    September 29, 2025
  • Biologics & Biosimilars,Drug approval,Drug Development,Market Access & Commercialization,Pharmaceuticals and therapeutics,Regulatory Affairs

    Biosimilars Forum highlights $181 billion in potential savings as lawmakers push for lower-cost medicines

    Proposed legislation aims to streamline biosimilar development and expand patient [...]

    September 30, 2025
  • Clinical Trials,Drug Development,Oncology,Regulatory Affairs

    UK approves cabozantinib Ipsen for previously treated advanced neuroendocrine tumours

    The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has [...]

    September 27, 2025
  • Artificial Intelligence,Clinical Development,Clinical studies,Drug Development,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    Leading global experts join judging panel for £7.5m Longitude Prize on ALS

    A panel of international leaders in neuroscience, artificial intelligence and [...]

    September 26, 2025
  • Biologics & Biosimilars,Chronic diseases,Clinical Development,Clinical Trials,Drug Development,Global health,Medical devices,Pharmaceuticals and therapeutics,Regulatory Affairs

    Hansa Biopharma reports statistically significant improvement in kidney function, supporting planned BLA submission

    Hansa Biopharma AB has announced positive topline results from the [...]

    September 26, 2025
  • Biotech,Clinical Development,Drug Development,European biotech,Events and Conferences,Partnerships & Funding,Pharmaceuticals and therapeutics,Women in Pharma

    CPHI Frankfurt Pharma Awards 2025 finalists unveiled, spotlighting innovation, sustainability and industry leadership

    From synthetic biology to patient access, AI-powered formulation to sustainable [...]

    September 26, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms

    ReiThera: Commercial CDMO capabilities key to manage ‘volatile’ biotech market

    ReiThera will begin commercial production in 2026, a milestone the [...]

    September 25, 2025
  • Artificial Intelligence,Cell & Gene Therapy,Drug Development,Research & Development,Technology and platforms

    AISB Network expands Federated OpenFold3 initiative with three new pharma contributors

    The AI Structural Biology (AISB) Network, powered by Apheris GmbH, [...]

    September 23, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Drug Development,Movers & Shakers,Pharmaceuticals and therapeutics,Technology and platforms

    DaltonTx raises £4 million seed financing to build AI-enabled drug discovery platform

    DaltonTx, a UK-based technology company, has exited stealth mode and [...]

    September 23, 2025
Previous101112Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Oncology, Pharmaceuticals and therapeutics, Research & Development
  • Aravax adds allergy specialists to board as peanut therapy advances
    Categories: Biotech, Clinical Development, Clinical Trials, Healthcare leadership, Immunology, Movers & Shakers
  • AI-derived drug candidate reduces fentanyl intake in preclinical opioid study
    Categories: Artificial Intelligence, Clinical studies, Drug discovery, Neurosciences, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top